Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study.

Background: Several treatment options were recently added for metastatic castration-resistant prostate cancer (mCRPC). However, response to therapy is variable, and biomarkers that can guide treatment selection and response evaluation are lacking. Circulating RNAs are a promising source of biomarker...

Descripción completa

Detalles Bibliográficos

Publicado en:	Clinical Chemistry Vol. 66; no. 6; pp. 842 - 852
Autores principales:	Benoist, Guillemette E., van Oort, Inge M., Boerrigter, Emmy, Verhaegh, Gerald W., van Hooij, Onno, Groen, Levi, Smit, Frank, de Mol, Pieter, Hamberg, Paul, Dezentjé, Vincent O., Mehra, Niven, Gerritsen, Winald, Somford, Diederik M., van Erp, Nielka P. H., Schalken, Jack A.
Formato:	Journal Article
Publicado:	Oxford University Press / USA Jun2020
Acceso en línea:	Ver este registro en EBSCOhost